| Dr Theodore Koichi Inouye, MD | |
|
34509 9th Ave S, Ste 208, Federal Way, WA 98003-8709 | |
| (253) 944-3278 | |
| (253) 944-4345 |
| Full Name | Dr Theodore Koichi Inouye |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 34509 9th Ave S, Federal Way, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124096649 | NPI | - | NPPES |
| 0246067 | Other | WA | STATE L&I |
| 1005073 | Medicaid | WA | |
| 8950424 | Other | WA | CRIME VICTIMS |
| 8536526 | Medicaid | WA | |
| G8879362 | Other | WA | MEDICARE |
| G8879361 | Other | WA | MEDICARE |
| 0246081 | Other | WA | L & I |
| 8536534 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD00022785 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theodore Koichi Inouye, MD 34509 9th Ave S, Ste 208, Federal Way, WA 98003-8709 Ph: (253) 944-3278 | Dr Theodore Koichi Inouye, MD 34509 9th Ave S, Ste 208, Federal Way, WA 98003-8709 Ph: (253) 944-3278 |
News Archive
Current recommendations that a central catheter is required for continuous intravenous infusion of 3 percent sodium chloride solution should be re-evaluated, according to a study in the American Journal of Critical Care.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
With increasing decentralization, new cell, gene and RNAI therapies, and a growing emphasis on patient self-care, many drug delivery device companies will need to rethink their strategies in order to remain competitive.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 7 days ago
Dr. Peter Vaughn Kilburn, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 34509 9th Ave S, Suite 309, Federal Way, WA 98003 Phone: 253-661-1814 Fax: 253-661-1489 | |
Gurteshwar Rana, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 34509 9th Ave S Ste 204, Federal Way, WA 98003 Phone: 253-835-5510 Fax: 253-835-5511 | |
Dr. Anna Hubbard, MD Surgery Medicare: Medicare Enrolled Practice Location: 34509 9th Ave S Ste 204, Federal Way, WA 98003 Phone: 253-835-5510 Fax: 253-835-5511 | |
Sameh Michael Salama, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 34509 9th Ave S Ste 204, Federal Way, WA 98003 Phone: 253-835-5510 Fax: 360-478-7241 | |
Dr. Michelle Lee Haslinger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 34509 9th Ave S Ste 204, Federal Way, WA 98003 Phone: 253-835-5510 Fax: 253-835-5511 | |
Dr. Richard Raymond Gould, MD Surgery Medicare: Medicare Enrolled Practice Location: 34509 9th Ave S Ste 204, Federal Way, WA 98003 Phone: 253-927-1800 Fax: 253-952-3025 |